An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)

NCT01026376 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: decitabine
DRUG: decitabine

Sponsor

Janssen-Cilag Farmaceutica Ltda.

Collaborators

[object Object]